EE04194B1 - Pentasahhariidid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid - Google Patents

Pentasahhariidid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid

Info

Publication number
EE04194B1
EE04194B1 EEP200000421A EEP200000421A EE04194B1 EE 04194 B1 EE04194 B1 EE 04194B1 EE P200000421 A EEP200000421 A EE P200000421A EE P200000421 A EEP200000421 A EE P200000421A EE 04194 B1 EE04194 B1 EE 04194B1
Authority
EE
Estonia
Prior art keywords
pentasaccharides
processes
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
EEP200000421A
Other languages
English (en)
Estonian (et)
Inventor
Petitou Maurice
Original Assignee
Sanofi-Synthlabo
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthlabo, Akzo Nobel N.V. filed Critical Sanofi-Synthlabo
Publication of EE200000421A publication Critical patent/EE200000421A/xx
Publication of EE200000421A1 publication Critical patent/EE200000421A1/xx
Publication of EE04194B1 publication Critical patent/EE04194B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078Degradation products

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Materials Engineering (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
EEP200000421A 1998-01-19 1999-01-13 Pentasahhariidid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid EE04194B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9800514A FR2773801B1 (fr) 1998-01-19 1998-01-19 Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
PCT/FR1999/000045 WO1999036428A1 (fr) 1998-01-19 1999-01-13 Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant

Publications (3)

Publication Number Publication Date
EE200000421A EE200000421A (et) 2001-12-17
EE200000421A1 EE200000421A1 (et) 2003-06-16
EE04194B1 true EE04194B1 (et) 2003-12-15

Family

ID=9521913

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000421A EE04194B1 (et) 1998-01-19 1999-01-13 Pentasahhariidid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid

Country Status (39)

Country Link
US (1) US6670338B1 (tr)
EP (1) EP1049706B1 (tr)
JP (1) JP4695756B2 (tr)
KR (1) KR100533565B1 (tr)
CN (1) CN1172948C (tr)
AR (1) AR012779A1 (tr)
AT (1) ATE241637T1 (tr)
AU (1) AU744137B2 (tr)
BR (1) BR9907100B1 (tr)
CA (1) CA2318326C (tr)
CO (1) CO4970823A1 (tr)
CZ (1) CZ299817B6 (tr)
DE (1) DE69908298T2 (tr)
DK (1) DK1049706T3 (tr)
DZ (1) DZ2706A1 (tr)
EE (1) EE04194B1 (tr)
EG (1) EG23760A (tr)
ES (1) ES2200494T3 (tr)
FR (1) FR2773801B1 (tr)
GT (1) GT199900006A (tr)
HK (1) HK1029999A1 (tr)
HR (1) HRP20000479B1 (tr)
HU (1) HU228335B1 (tr)
IL (2) IL137240A0 (tr)
MY (1) MY125636A (tr)
NO (1) NO316894B1 (tr)
NZ (1) NZ505614A (tr)
PL (1) PL191098B1 (tr)
PT (1) PT1049706E (tr)
RU (1) RU2193040C2 (tr)
SA (1) SA99191114B1 (tr)
SI (1) SI1049706T1 (tr)
SK (1) SK284176B6 (tr)
TR (1) TR200002077T2 (tr)
TW (1) TW550267B (tr)
UA (1) UA61124C2 (tr)
UY (1) UY25357A1 (tr)
WO (1) WO1999036428A1 (tr)
ZA (1) ZA99357B (tr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
DK1569912T3 (en) 2002-12-03 2015-06-29 Pharmacyclics Inc 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors.
CN100338084C (zh) * 2004-07-02 2007-09-19 北京大学 抑制异种器官移植免疫排斥反应的五糖抗原的合成方法
FR2874924B1 (fr) 2004-09-09 2006-12-01 Sanofi Aventis Sa Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) * 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
US20070191306A1 (en) * 2005-08-17 2007-08-16 Bristol-Myers Squibb Company FACTOR Xa INHIBITOR FORMULATION AND METHOD
EP1908768A1 (en) * 2006-10-05 2008-04-09 Endotis Pharma Anticoagulant compounds
WO2009155108A1 (en) 2008-05-30 2009-12-23 Momenta Pharmaceuticals, Inc. Saccharide structures and methods of making and using such structures
EP2323605A4 (en) * 2008-09-10 2014-02-05 Syneron Medical Ltd TRANSDERMAL RELEASE OF OLIGOSACCHARIDES
WO2011014793A2 (en) 2009-07-31 2011-02-03 Reliable Biopharmaceutical Corporation Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof
US8420790B2 (en) 2009-10-30 2013-04-16 Reliable Biopharmaceutical Corporation Efficient and scalable process for the manufacture of Fondaparinux sodium
EP2721044B1 (en) * 2011-06-17 2015-11-18 Carbomimetics Synthetic pentasaccharides having short half-life and high activity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300099A1 (en) * 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
IL102758A (en) * 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
ATE190619T1 (de) * 1993-09-01 2000-04-15 Akzo Nobel Nv Biskonjugate, die zwei saccharide und einen spacer enthalten
FR2751334B1 (fr) * 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
FR2773801B1 (fr) 2000-05-12
HUP0102042A1 (hu) 2001-10-28
CZ20002636A3 (cs) 2000-11-15
AU1974699A (en) 1999-08-02
SK284176B6 (sk) 2004-10-05
TR200002077T2 (tr) 2000-12-21
US6670338B1 (en) 2003-12-30
IL137240A0 (en) 2001-07-24
FR2773801A1 (fr) 1999-07-23
DE69908298D1 (de) 2003-07-03
NZ505614A (en) 2003-02-28
TW550267B (en) 2003-09-01
NO20003661D0 (no) 2000-07-17
KR100533565B1 (ko) 2005-12-06
WO1999036428A1 (fr) 1999-07-22
HK1029999A1 (en) 2001-04-20
DK1049706T3 (da) 2003-09-29
ATE241637T1 (de) 2003-06-15
CO4970823A1 (es) 2000-11-07
JP2002509154A (ja) 2002-03-26
PL191098B1 (pl) 2006-03-31
AR012779A1 (es) 2000-11-08
SK10792000A3 (sk) 2001-01-18
EP1049706B1 (fr) 2003-05-28
RU2193040C2 (ru) 2002-11-20
HRP20000479A2 (en) 2001-02-28
EE200000421A1 (et) 2003-06-16
ZA99357B (en) 2000-07-19
GT199900006A (es) 2000-07-12
DE69908298T2 (de) 2004-04-01
UA61124C2 (en) 2003-11-17
EG23760A (en) 2007-08-08
HUP0102042A3 (en) 2003-07-28
CA2318326C (en) 2010-07-06
PL341874A1 (en) 2001-05-07
CZ299817B6 (cs) 2008-12-03
CN1172948C (zh) 2004-10-27
CN1293679A (zh) 2001-05-02
CA2318326A1 (en) 1999-07-22
ES2200494T3 (es) 2004-03-01
EP1049706A1 (fr) 2000-11-08
IL137240A (en) 2007-10-31
NO20003661L (no) 2000-09-19
JP4695756B2 (ja) 2011-06-08
MY125636A (en) 2006-08-30
HU228335B1 (en) 2013-03-28
HRP20000479B1 (en) 2006-04-30
UY25357A1 (es) 2000-12-29
AU744137B2 (en) 2002-02-14
EE200000421A (et) 2001-12-17
BR9907100B1 (pt) 2013-09-03
SI1049706T1 (en) 2003-12-31
PT1049706E (pt) 2003-09-30
SA99191114B1 (ar) 2006-10-11
BR9907100A (pt) 2000-10-24
DZ2706A1 (fr) 2003-09-01
NO316894B1 (no) 2004-06-14
KR20010034205A (ko) 2001-04-25

Similar Documents

Publication Publication Date Title
EE200000168A (et) Karboksamidotiasoolderivaadid, nende valmistamine ja neid sisaldavad farmatseutilised kompositsioonid
EE200000791A (et) Uudsed atsüülpseudopeptiidid, nende valmistamise meetod ja neid sisaldavad farmatseutilised kompositsioonid
EE200000707A (et) Oksasolidinooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE200200138A (et) Kinolüülpropüülpiperidiini derivaadid, nende valmistamine ja neid sisaldavad kompositsioonid
EE04498B1 (et) Erütromütsiini derivaadid, nende valmistamismeetod ja neid sisaldav farmatseutiline kompositsioon
EE05183B1 (et) Asabitsklilised hendid, nende valmistamine ja kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon
EE05034B1 (et) Bitsüklilised heterotsüklilised ühendid, neid ühendeid sisaldavad farmatseutilised kompositsioonid ja nende valmistamise meetodid
EE200200149A (et) Kinasoliinühendid ja neid sisaldavad ravimkoostised
EE9800028A (et) Iprotroopiumsoolad, neid sisaldavad ravimkompositsioonid ja nende kasutamine
EE04853B1 (et) Adenosiini derivaadid ja neid sisaldavad farmatseutilised kompositsioonid kasutamiseks meditsiinis
EE04276B1 (et) Kinoliini derivaadid, nende valmistamine ja kasutamine ravimina ning neid sisaldavad farmatseutilised kompositsioonid
HUP0201953A3 (en) Benzene derivatives, preparation method and pharmaceutical compositions containing same
DK1112266T3 (da) Substituerede 4-amino-2-arylpyrimidiner, fremstilling og anvendelse deraf og farmaceutiske præparater indeholdende dem
EE9800426A (et) Asendatud 2,4-tiasolidiindiooni derivaadid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid
PL345354A1 (en) 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
EE03929B1 (et) Sünteetilised polüsahhariidid, nende valmistamisemeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE200000429A1 (et) Sünteetilised polüsahhariidid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid
EE04194B1 (et) Pentasahhariidid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid
EE200100027A (et) Fosfororgaanilised ühendid, neid sisaldav farmatseutiline preparaat ja nende kasutamine
EE200200022A (et) Aminotiasooli derivaadid, nende valmistamine ja neid sisaldavad farmatseutilised kompositsioonid
EE03611B1 (et) Taksoidid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
NO960272L (no) Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
HUP0104834A2 (hu) Szulfoniloxazol-aminok, alkalmazásuk, e vegyületeket tartalmazó gyógyászati készítmények és előállításuk
NO20002114D0 (no) Bicykliske forbindelser, fremgangsmÕte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem

Legal Events

Date Code Title Description
HH1A Change of representative
KB4A Valid patent at the end of a year

Effective date: 20031231

GB1A Change in the ownership or in the address of the owner
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231